Avelumab
Definition: Avelumab, sold under the brand name Bavencio, is a fully human monoclonal antibody medication for the treatment of Merkel cell carcinoma, urothelial carcinoma, and renal cell carcinoma. Common side effects include fatigue, musculoskeletal pain, diarrhea, nausea, infusion-related reactions, rash, decreased appetite and swelling of the limbs (peripheral edema). Avelumab targets the protein programmed death-ligand 1 (PD-L1). source: Wikipedia
- ID
- 733055009
- ID date
- 6 Oct 2017
- Previous ID
- 34714111000001101
- Name
- Avelumab